Intrinsic differences in cisplatin sensitivity of head and neck cancer cell lines: Correlation to lysosomal pH

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Head and Neck

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hed.21317PMID 20029982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines.

  2009cited by this paper
• Proteomic Analysis of Laser-Captured Paraffin-Embedded Tissues: A Molecular Portrait of Head and Neck Cancer Progression

  2008cited by this paper
• Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture.

  2008cited by this paper
• Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer

  2007cited by this paper
• Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma.

  2007cited by this paper
• Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?

  2007cited by this paper
• The chemoradiation paradigm in head and neck cancer

  2007cited by this paper
• Cisplatin Preferentially Binds Mitochondrial DNA and Voltage-Dependent Anion Channel Protein in the Mitochondrial Membrane of Head and Neck Squamous Cell Carcinoma: Possible Role in Apoptosis

  2006cited by this paper
• Endocytic recycling compartments altered in cisplatin-resistant cancer cells.

  2006cited by this paper
• Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis.

  2006cited by this paper
• Cysteine cathepsins: multifunctional enzymes in cancer

  2006cited by this paper
• Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death

  2005cited by this paper
• Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma

  2005cited by this paper
• Cellular processing of platinum anticancer drugs

  2005influential reference
• Lysosomes and autophagy in cell death control

  2005cited by this paper
• Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

  2005cited by this paper
• Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells.

  2005cited by this paper
• Multiple cell death pathways as regulators of tumour initiation and progression

  2004cited by this paper
• Defective Acidification of Intracellular Organelles Results in Aberrant Secretion of Cathepsin D in Cancer Cells*

  2004cited by this paper
• Alcohol dehydrogenase 3 transcription associates with proliferation of human oral keratinocytes

  2004cited by this paper
• Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS).

  2004cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003influential reference
• Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry.

  2003cited by this paper
• Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines

  2003cited by this paper
• Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines.

  2003cited by this paper
• Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine

  2003cited by this paper
• Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor

  2001cited by this paper
• Is cisplatin-induced cell death always produced by apoptosis?

  2001influential reference
• Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes.

  2000cited by this paper
• Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c.

  2000cited by this paper
• Structure and Properties of the Vacuolar (H+)-ATPases*

  1999cited by this paper
• Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress.

  1999cited by this paper
• Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes.

  1998cited by this paper
• Potential role for Cathepsin D in p53-dependent tumor suppression and chemosensitivity

  1998cited by this paper
• Serum-free growth and karyotype analyses of cultured normal and tumorous (SqCC/Y1) human buccal epithelial cells.

  1991cited by this paper
• Localization of cathepsin B in two human lung cancer cell lines.

  1990cited by this paper
• Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).

  1987cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Lysosome pH Dynamics in Physiology and Disease: Molecular Mechanisms and Therapeutic Insights

  2026cites this paper
• Lysosomes as Dynamic Regulators of Metabolic Signaling and Organ Physiology in Aging: From Mechanism to Therapy

  2025cites this paper
• SLC46A3 is a lysosomal proton-coupled steroid conjugate and bile acid transporter involved in transport of active catabolites of T-DM1

  2022cites this paper
• Transformable amyloid-beta mimetic peptide amphiphiles for lysosomal disruption in non-small cell lung cancer.

  2021cites this paper
• Innovative pH-interfering agents in association with anticancer agents

  2021cites this paper
• Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition

  2020cites this paper
• Using Ligand-Accelerated Catalysis to Repurpose Fluorogenic Reactions for Platinum or Copper

  2020cites this paper
• pHLARE: A Genetically Encoded Ratiometric Lysosome pH Biosensor

  2020influential citation
• pHLARE: a new biosensor reveals decreased lysosome pH in cancer cells

  2020cites this paper
• Dissecting the Proton Transport Pathway in Oral Squamous Cell Carcinoma: State of the Art and Theranostics Implications

  2019cites this paper
• Modulation of RAB7A Protein Expression Determines Resistance to Cisplatin through Late Endocytic Pathway Impairment and Extracellular Vesicular Secretion

  2019cites this paper
• The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing NOTCH1 Expression and Targeting Tumor-Initiating Cells.

  2018cites this paper
• The FACT inhibitor CBL 0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing NOTCH 1 Expression and Targeting Tumor-Initiating Cells

  2018cites this paper
• Salvianolic acid B protects hepatocytes from H2O2 injury by stabilizing the lysosomal membrane

  2017cites this paper
• Analysis of Lysosomal pH by Flow Cytometry Using FITC-Dextran Loaded Cells.

  2017cites this paper
• Up-regulation of HB-EGF by the COX-2/PGE2 signaling associates with the cisplatin resistance and tumor recurrence of advanced HNSCC.

  2016cites this paper
• Autophagy Enhancers, are we there Yet?

  2016cites this paper
• Integrating chromatin structure and global chromosome dynamics

  2015cites this paper
• Platinum (IV) coiled coil nanotubes selectively kill human glioblastoma cells.

  2015cites this paper
• New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants.

  2015cites this paper
• Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc

  2015cites this paper
• The lysosome: from waste bag to potential therapeutic target.

  2013cites this paper
• The histone deacetylase inhibitor trichostatin A reduces lysosomal pH and enhances cisplatin-induced apoptosis.

  2013influential citation
• NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)

  2013cites this paper
• Lysosomal Membrande Stability and Cathepsins in Cell Death

  2012cites this paper
• Subcellular targets of cisplatin cytotoxicity: an integrated view.

  2012cites this paper
• Lysosomes

  1966cites this paper